soul trial oral semaglutide cardiovascular outcomes 2024 results nejm

soul trial oral semaglutide cardiovascular outcomes 2024 results nejm and in Patients with Type 2 Diabetes NEJM Editorial Fellow Harleen Marwah,

Name: soul trial oral semaglutide cardiovascular outcomes 2024 results nejm and in Patients with Type 2 Diabetes NEJM Editorial Fellow Harleen Marwah,
Brand: ctstranslates.com
SKU: 44339636558
Price: 28.89 USD
Availability: InStock
Rating: 4.0045 (24 reviews)

SKU: 44339636558

4.0

EUR28.89 EUR49.89

Pay in 4 interest-free payments of $7.22 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 7 - Aug 12

Description

When taking a GLP-1 for weight loss, it is important to eat a nutritionally balanced diet in conjunction with treatment, namely adequate protein

Published 2024 Sep 18

Tabei SM, Mazloom M, Shahriari M, Zareifar S, Azimi A, Hadaegh A, Karimi M

Journal of Diabetes Science and Technology, 17 (6), 17111721

GLP-1 medications such as Ozempic and Wegovy are now widely marketed to help treat obesity, but there has also been a rise in companies selling unauthorised drugs or treatments